Cargando…

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529955/ https://www.ncbi.nlm.nih.gov/pubmed/34691087 http://dx.doi.org/10.3389/fimmu.2021.782687

Ejemplares similares

Immunotherapy for Glioblastoma: Current Progress and Challenges
por: Yu, Miranda W., et al.
Publicado: (2021)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions
por: Wang, Mingming, et al.
Publicado: (2023)

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
por: Zhang, Peng, et al.
Publicado: (2022)

Clinical cancer immunotherapy: Current progress and prospects
por: Liu, Chenglong, et al.
Publicado: (2022)

Current Challenges for IDO2 as Target in Cancer Immunotherapy
por: Mondanelli, Giada, et al.
Publicado: (2021)

Putting Proteomics Into Immunotherapy for Glioblastoma
por: Chen, Liangyu, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
por: Tang, Lin, et al.
Publicado: (2022)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
por: Yang, Minfeng, et al.
Publicado: (2020)

Glioblastoma Immune Landscape and the Potential of New Immunotherapies
por: Daubon, Thomas, et al.
Publicado: (2020)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
por: Majc, Bernarda, et al.
Publicado: (2021)

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
por: Rose, Mélanie, et al.
Publicado: (2021)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
por: Hu, Weilei, et al.
Publicado: (2019)

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
por: Riet, Tobias, et al.
Publicado: (2022)

Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection
Publicado: (2023)

Lymphoma Immunotherapy: Current Status
por: Zappasodi, Roberta, et al.
Publicado: (2015)

Current Advances in Immunotherapy for Glioblastoma
por: Mende, Abigail L., et al.
Publicado: (2021)

Current Studies of Immunotherapy on Glioblastoma
por: Agrawal, Neena Stephanie, et al.
Publicado: (2014)

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
por: Feng, Peng, et al.
Publicado: (2022)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Erratum: Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing
Publicado: (2022)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
por: Wang, Zide, et al.
Publicado: (2022)

The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Research Progress in the Application of Exosomes in Immunotherapy
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Current State of Immunotherapy for Treatment of Glioblastoma
por: McGranahan, Tresa, et al.
Publicado: (2019)

Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
por: Hu, Jinyang, et al.
Publicado: (2020)

Immune landscape-based machine-learning–assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma
por: Li, Haiyan, et al.
Publicado: (2022)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

Cold Tumors: A Therapeutic Challenge for Immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2019)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
por: Morrison, Hazel, et al.
Publicado: (2023)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
por: Li, Long, et al.
Publicado: (2020)

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sn1thcpq7c9dat4csj1ql40c53